Neurogene Inc. Earnings Per Share, Basic and Diluted
Neurogene Inc. (NGNE) reported Earnings Per Share, Basic and Diluted of -$0.64 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-25
- Neurogene Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.04.
- Neurogene Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.20.
- Neurogene Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.18.
- Neurogene Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$2.26.
- Neurogene Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.64.
- Neurogene Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.57.
- Neurogene Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.34.
- Neurogene Inc. earnings per share, basic and diluted for fiscal 2017 was -$2.14.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 123 month |
|---|---|---|---|---|---|
| 2020-12-31 | -$0.64 10-K · filed 2021-03-25 | ||||
| 2020-09-30 | -$0.04 10-Q · filed 2020-11-09 | -$0.41 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | -$0.20 10-Q · filed 2020-08-12 | -$0.37 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | -$0.18 10-Q · filed 2020-05-06 | ||||
| 2019-12-31 | -$2.57 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | -$2.26 10-Q · filed 2020-11-09 | -$2.51 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | -$0.09 10-Q · filed 2020-08-12 | ||||
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | -$1.34 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | -$0.64 10-Q · filed 2019-11-13 | -$1.14 10-Q · filed 2019-11-13 | |||
| 2018-03-31 | -$0.62 10-Q · filed 2019-05-07 | ||||
| 2017-12-31 | -$2.14 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$0.50 10-Q · filed 2018-11-07 | -$1.45 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | -$0.59 10-Q · filed 2017-08-08 | -$0.94 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | -$0.36 10-Q · filed 2018-05-08 | ||||
| 2016-12-31 | -$1.96 10-K · filed 2019-03-07 | ||||
| 2016-09-30 | -$0.46 10-Q · filed 2017-11-08 | -$1.48 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | -$0.63 10-Q · filed 2017-08-08 | -$1.02 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | -$0.39 10-Q · filed 2017-05-09 | ||||
| 2015-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$1.16 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$1.73 10-K · filed 2018-03-12 | |
| 2015-09-30 | -$0.43 10-Q · filed 2016-11-09 | -$0.87 derived: net income ÷ weighted average shares · filed 2016-11-09 | -$1.46 10-Q · filed 2016-11-09 | -$2.21 derived: net income ÷ weighted average shares · filed 2017-03-09 | |
| 2015-06-30 | -$0.44 10-Q · filed 2016-08-04 | -$1.04 10-Q · filed 2016-08-04 | -$1.80 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$2.38 derived: net income ÷ weighted average shares · filed 2017-03-09 | |
| 2015-03-31 | -$0.60 10-Q · filed 2016-05-10 | -$1.35 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$1.94 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$2.45 derived: net income ÷ weighted average shares · filed 2017-03-09 | |
| 2014-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$1.34 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$1.85 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$2.75 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$0.59 10-Q · filed 2015-11-10 | -$1.10 derived: net income ÷ weighted average shares · filed 2015-11-10 | -$1.97 10-Q · filed 2015-11-10 | -$3.39 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2014-06-30 | -$0.51 10-Q · filed 2015-08-06 | -$1.43 10-Q · filed 2015-08-06 | -$3.13 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$5.39 derived: net income ÷ weighted average shares · filed 2016-03-14 | |
| 2014-03-31 | -$1.28 10-Q · filed 2015-05-12 | -$5.39 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$11.21 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$16.19 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$179.45 10-Q · filed 2014-05-13 |
| 2013-12-31 | -$17.50 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$33.14 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$41.04 derived: net income ÷ weighted average shares · filed 2016-03-14 | -$49.52 10-K · filed 2016-03-14 | |
| 2013-09-30 | -$15.64 10-Q · filed 2014-11-04 | -$23.54 derived: net income ÷ weighted average shares · filed 2014-11-04 | -$32.02 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | -$7.89 10-Q · filed 2014-08-11 | -$16.37 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | -$8.48 10-Q · filed 2014-05-13 | ||||
| 2012-12-31 | -$40.23 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |